Common variant in betaine-homocysteine methyltransferase (BHMT) and risk for spina bifida.

Common variant in betaine-homocysteine methyltransferase (BHMT) and risk for spina bifida. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Common variant in betaine-homocysteine methyltransferase (BHMT) and risk for spina bifida. Abstract Text:

Neural tube defects (NTD) are common malformations resulting from incomplete closure of the neural tube in the first month after conception. Since genetic deficiencies in folate-dependent homocysteine metabolism have been identified in NTD families, we investigated a common variant in betaine-homocysteine methyltransferase (BHMT), 742G-->A (R239Q), as a genetic modifier of NTD risk. Genotypes, nutrient levels, and plasma total homocysteine (tHcy) were assessed in 54 patients with spina bifida, 57 mothers of patients, 93 control children, and 86 mothers of controls. The QQ genotype (present in 17% and 7% of the control and case mothers, respectively, and in 12% and 6% of the control and case children, respectively) was associated with a decreased risk of NTD (odds ratios of 0.52 (95% CI 0.13-2.05) for children and 0.37 (95% CI 0.11-1.22) for mothers). The small sample size limited the statistical power of the analyses, but these decreases, although not statistically significant, are compatible with a protective effect. We did not observe statistically-significant genotype-dependent differences in plasma homocysteine, although women with the QQ genotype did have lower homocysteine; in children, the mean homocysteine level was higher in the QQ group. This inconsistency could be explained by the fact that age is a strong determinant of homocysteine in children and the QQ group was on average older than the other genotype groups. Our study suggests that the Q allele of the R239Q mutation may decrease risk of the condition. This warrants further investigation of its relationship with the development of NTD.

Common variant in betaine-homocysteine methyltransferase (BHMT) and risk for spina bifida. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Common variant in betaine-homocysteine methyltransferase (BHMT) and risk for spina bifida. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: American journal of medical genetics. Part A

VOLUME: 119A

Page Numbers: 172-6

Journal Abbreviation: Am. J. Med. Genet. A

ISSN: 1552-4825

DAY: 1

MONTH: Jun

YEAR: 2003

Common variant in betaine-homocysteine methyltransferase (BHMT) and risk for spina bifida. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101235741

Common variant in betaine-homocysteine methyltransferase (BHMT) and risk for spina bifida. Keywords Mesh Terms:

KEYWORDS: Variation (Genetics)

MESH TERMS: genetics

Chemical & Substance for Abstract: Common variant in betaine-homocysteine methyltransferase (BHMT) and risk for spina bifida. Information

Substance Name: Betaine-Homocysteine S-Methyltransferase

Registry Number: EC 2.1.1.5

Grant and Affiliation Information for Common variant in betaine-homocysteine methyltransferase (BHMT) and risk for spina bifida.

AFFILIATION: Department of Pediatrics, McGill University-Montreal Children's Hospital Research Institute, Montreal, Canada.

Country: United States

AGENCY: United States NHLBI

GRANT: HL58955-01

ACRONYM:

MEDLINETA: Am J Med Genet A

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Common variant in betaine-homocysteine methyltransferase BHMT and risk for spina bifida Related Publications

• Acroangiodermatitis.
• Atypical presentations of cluster headache.
• Betaine supplementation improves the atherogenic risk factor profile in a transgenic mouse model of hyperhomocysteinemia.
• Clomiphene citrate for treatment refractory chronic cluster headache.
• Common variant in betaine-homocysteine methyltransferase (BHMT) and risk for spina bifida.
• Constructing the OCF2O Moiety Using BrF3.
• Endoplasmic Reticulum Stress Increases the Expression of Methylenetetrahydrofolate Reductase through the IRE1 Transducer.
• Genetic and nutritional deficiencies in folate metabolism influence tumorigenicity in Apcmin/+ mice.
• Hemicrania continua with aura.
• Homocysteine modulates the effect of simvastatin on expression of ApoA-I and NF-{kappa}B/iNOS.
• Interview.
• Lipoid hepatitis and dermatitis vegetans(?).
• Mefolinate (5-methyltetrahydrofolate), but not folic acid, decreases mortality in an animal model of severe methylenetetrahydrofolate reductase deficiency.
• Melatonin in the preventive treatment of chronic cluster headache.
• Melkersson-Rosenthal syndrome presenting as a new daily persistent headache: relief with dapsone.
• Methylenetetrahydrofolate reductase (MTHFR): a novel target for cancer therapy.
• Modular headache theory.
• Non-hypothalamic cluster headache: the role of the greater occipital nerve in cluster headache pathogenesis.
• Polymorphisms in methionine synthase reductase and betaine-homocysteine S-methyltransferase genes: risk of placental abruption.
• Strain differences in mice highlight the role of DNA damage in neoplasia induced by low dietary folate.
• The clinical characteristics of new daily persistent headache.
• Valproic acid increases expression of methylenetetrahydrofolate reductase (MTHFR) and induces lower teratogenicity in MTHFR deficiency.
• Verapamil-responsive hemicrania continua in a patient with episodic cluster headache.
• [Acute compartment syndrome in the thigh]
• [Effect of several endocrine factors on the concentration of specific estrogen-binding protein in rat liver]
• [Effect of thyroid hormones on the complexing of hydrocortisone with transcortin in gonadectomized guinea pigs]
• [Multi-component system of proteins binding estradiol in rat liver cytosol. Relationship to sex steroids]
• [Multicomponent system of estrogen-binding proteins of liver cytosol: species differences in rats, mice and guinea pigs]
• [Nuclear estradiol receptors in several "non-target" organs of rats]
• [ON THE FUNCTIONAL STATE OF THE ADRENAL CORTEX IN EXPERIMENTAL MODELS OF RHEUMATISM.]